BioMarin Pharmaceutical Inc.

Historical 13F Holders

Symbol
BMRN
CUSIP
09061G101
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 09061G101 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 10.0% 11/4/2026
Event 10/31/2026
Primecap Management Co/CA/ 13G/A 8.2% 8/14/2025
Event 6/30/2025
Vanguard Capital Management LLC 13G 5.3% 4/29/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Capital Research Global Investors 13G/A 4.8% 5/13/2025
Event 3/31/2025
Viking Global Investors LP 13G/A
4.3% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 309 37.9 M $2.27B
2026 Q2 571 194 M $12.0B
2026 Q1 565 184 M $10.4B
2025 Q4 549 188 M $11.2B
2025 Q3 587 180 M $9.72B
2025 Q2 591 184 M $10.1B
2025 Q1 592 187 M $13.1B
2024 Q4 552 183 M $12.0B
2024 Q3 563 180 M $12.7B
2024 Q2 566 185 M $15.2B
2024 Q1 568 187 M $16.3B
2023 Q4 559 186 M $17.9B
2023 Q3 528 182 M $16.4B
2023 Q2 566 179 M $15.5B
2023 Q1 562 179 M $17.4B
2022 Q4 587 183 M $18.9B
2022 Q3 559 182 M $15.5B
2022 Q2 547 179 M $14.9B
2022 Q1 564 178 M $13.7B
2021 Q4 564 177 M $15.7B
2021 Q3 517 176 M $13.6B
2021 Q2 534 177 M $14.7B
2021 Q1 537 178 M $13.5B
2020 Q4 549 183 M $16.1B
2020 Q3 506 179 M $13.6B
2020 Q2 539 181 M $22.3B
2020 Q1 509 177 M $15.0B
2019 Q4 474 174 M $14.7B
2019 Q3 441 174 M $11.7B
2019 Q2 485 178 M $15.3B
2019 Q1 490 179 M $15.9B
2018 Q4 481 179 M $15.3B
2018 Q3 467 182 M $17.7B
2018 Q2 456 184 M $17.3B
2018 Q1 436 180 M $14.6B
2017 Q4 442 178 M $15.8B
2017 Q3 415 175 M $16.3B
2017 Q2 429 171 M $15.6B
2017 Q1 424 169 M $14.8B
2016 Q4 419 169 M $14.0B
2016 Q3 430 168 M $15.6B
2016 Q2 400 160 M $12.4B
2016 Q1 398 166 M $13.4B
2015 Q4 396 168 M $17.1B
2015 Q3 401 159 M $16.8B
2015 Q2 394 158 M $21.6B
2015 Q1 385 157 M $19.5B
2014 Q4 346 148 M $13.4B
2014 Q3 318 148 M $10.7B
2014 Q2 322 145 M $8.99B
2014 Q1 314 151 M $10.4B